|
Weekly-market: Bulls extend their stay for 2nd week; Midcap, Smallcap Underperform
|
Friday, July 25, 2014 |
| Market Commentary | | Bulls extend their stay for 2nd week; Midcap, Smallcap Underperform | The Indian markets ended in the positive terrain for the second consecutive week. The Sensex up 1.89% and the Nifty rose 1.65% |
Major Headlines for the week: Indian indices: Welcome to the 'Weekly Market Wrap' for July 25, 2014 Indian markets retreated from record high, as decline on last trading day of the week capped gains in Indian markets in the week ended on July 25, 2014. The barometer index, the S&P BSE Sensex, and the 50-unit CNX Nifty, both, retreated after scaling record high in intraday trade on July 25, 2014. The market gained in four out of five trading sessions in the week just gone by. The BSE Mid-Cap and the BSE Small-Cap indices underperformed the Sensex during the week. The S&P BSE Mid-Cap index fell 74.59 points or 0.8% to 9,178.21. The S&P BSE Small-Cap index declined 143.67 points or 1.41% to 10,037.17. Both these indices underperformed the Sensex. The BSE Sensex surged 1,265 points in the past eight trading days between July 15 and July 24. ICICI Bank, Reliance Industries, Tata Consultancy Services (TCS), Housing Development Finance Company (HDFC) and Infosys contributed a combined 659 points or 52% to the 1,265-point rally in the Sensex. Sensex scaled a record high of 26,300.17 while Nifty hit record high of 7,840.95, in intraday trade on Friday, July 25, 2014 The 30-share S&P BSE Sensex gained 485.19 points or 1.89% to 26,126.75 while CNX Nifty advanced 126.55 points or 1.65% to 7,790.45 Weekly market trend from July 21 - July 25: July 21- The BSE Sensex rose for a fifth consecutive session on Monday as RIL rallied after its quarterly earnings beat estimates, while merger-related news led to gains in shares of some companies such as Kotak Mahindra Bank. The Sensex closed at 25715.17, up by 73.61 points, while the Nifty rose 20.30 points to close at 7684.20. July 22- Indian shares rose more than 1% on Tuesday, approaching their record highs hit earlier this month after telecom stocks surged following Idea Cellular' better-than-expected earnings while stronger Asian shares also bolstered sentiments. The 30-share Sensex ended up 311 points at 26,026 after hitting an intra-day high of 26,050 and the 50-share Nifty gained 84 points to close at 7,768 after touching a high of 7,774. July 23- India's NSE index marked its record closing high on Wednesday, led by gains in technology stocks on continued foreign-investor buying, while firm cues from Asian markets also aided sentiment. The S&P BSE Sensex gained 121.53 points and ended at 26147.33 while the CNX Nifty ended 27.90 points higher at 7,795.75. July 24- India's NSE index rose to a record high for a second straight session on Thursday after cabinet approval for a higher FDI limit in insurance and a rejig in foreign debt limits reinforced optimism about the government's reform agenda. The S&P BSE Sensex gained 124.52 points and ended at 26271.85 while the CNX Nifty ended 34.85 points higher at 7830.60. July 25- India's NSE index fell on Friday after hitting a record high for a third straight day as investors took profits in blue-chips such as ICICI Bank , while software stocks declined after Wipro's U.S. dollar revenue growth lagged rivals. The Sensex closed at 26126.75, down by 145.10 points, while the Nifty fell 40.15 points to close at 7790.45. Global indices: Majority of the global markets closed in green, barring Dow Jone which were modestly down by 0.10%. The topmost gainers are: Shanghai Composite up by 3.28%, Hang Seng up by 3.25%, CAC 40 up by 1.74%, Nikkei up by 1.59% and Nasdaq up by 0.90%. Sectoral and stock screening: Top Gainers: S&P BSE IT up 4.14%, S&P BSE Teck up 3.66% and S&P BSE FMCG up 3.57%. Top Losers: S&P BSE Power down 3.36%, S&P BSE Realty down 2.84% and S&P BSE CG down 2.23%. | Looking at the 'A' group stocks, the top three gainers of the week were - Financial Tech up 29.83%, Wockhardt up 18.81% and Glenmark Pharma up 14.37%. Top three losers of the week were - Ipca Labs fell by 15.93%, JP Associates fell by 11.90% and Cairn India down 10.16%. FII/MF activity The foreign institutional investors (FIIs) have been the net buyers of the Indian stocks to the tune of Rs1456.700 crore as on July 23, 2014 and the domestic investors bought Indian shares worth a net of Rs253.30 crore as on July 22, 2014. | TOP MOVERS (GROUP A) |  | | | | | Financial Tech | 348.00 | 29.83 | | | Glenmark Pharma | 637.00 | 14.37 | | | | JP Associates | 59.25 | -11.90 | | Cairn India | 309.00 | -10.16 | | | | | | FII/MF ACTIVITIES |  | | | | Gross purchase | 9,998.3 | 1,420.5 | | Gross sale | 8,541.5 | 1,167.2 | | Net investment | 1,456.7 | 253.3 | | | | | | | | *Data as on July 23, 2014 **Data as on July 22, 2014 | | | Market Outlook for the coming week! In the coming week, Corporate earnings will continue to dictate market trend in the truncated trading week. The market may remain volatile as traders roll over positions in the futures & options (F&O) segment from the near month July 2014 series to August 2014 series. The near-month July 2014 F&O contracts expire on Thursday, 31 July 2014. On global economic front, the outcome of the two-day Federal Open Market Committee (FOMC) monetary policy review which concludes on 30 July 2014 will be closely watched. Trend in investment by foreign portfolio investors (FPIs), trend in global markets, trend in other global emerging markets, the movement of rupee against the dollar, crude oil price movement and progress of monsoon will be also closely tracked by the investors. India's stock market remains closed on Tuesday, 29 July 2014, on account of Ramzan Id. In macro economic data, Markit Economics will unveil the results of a monthly survey on India's manufacturing sector for July 2014 on Friday, 1 August 2014. Shares of automobile companies will be in focus as auto companies start unveiling sales volume data for July 2014 from Friday, 1 August 2014. Shares of public sector oil marketing companies (PSU OMCs) will be in focus as a monthly revision in diesel prices is due at the end of the month. | | To know more about our products and services, click here. | | Regd Add: Sharekhan Limited, 10th Floor, Beta Building, Lodha iThink Techno Campus, Off. JVLR, Opp. Kanjurmarg Railway Station, Kanjurmarg (East), Mumbai - 400042, Maharashtra. Tel: 022 - 61150000. Fax: 67481899; E-mail: publishing@sharekhan.com; Website: www.sharekhan.com; CIN: U99999MH1995PLC087498. Sharekhan Ltd.: SEBI Regn. Nos. BSE- INB/INF011073351 ; CD-INE011073351; NSE- INB/INF231073330 ; CD-INE231073330; MCX Stock Exchange- INB/INF261073333 ; CD-INE261073330; DP-NSDL-IN-DP-NSDL-233-2003 ; CDSL-IN-DP-CDSL-271-2004 ; PMS-INP000000662 ; Mutual Fund-ARN 20669 ; Commodity trading through Sharekhan Commodities Pvt. Ltd.: MCX-10080 ; (MCX/TCM/CORP/0425) ; NCDEX-00132 ; (NCDEX/TCM/CORP/0142) ; NCDEX SPOT-NCDEXSPOT/116/CO/11/20626; For any complaints email at igc@sharekhan.com ; Disclaimer: Client should read the Risk Disclosure Document issued by SEBI & relevant exchanges and Do's & Don'ts by MCX & NCDEX and the T & C on www.sharekhan.com before investing. | | | "This document has been prepared by Sharekhan Ltd. This Document is subject to changes without prior notice and is intended only for the person or entity to which it is addressed to and may contain confidential and/or privileged material and is not for any type of circulation. Any review, retransmission, or any other use is prohibited. Kindly note that this document does not constitute an offer or solicitation for the purchase or sale of any financial instrument or as an official confirmation of any transaction. Though disseminated to all the customers simultaneously, not all customers may receive this report at the same time. SHAREKHAN will not treat recipients as customers by virtue of their receiving this report. The information contained herein is from publicly available data or other sources believed to be reliable. While we would endeavour to update the information herein on reasonable basis, SHAREKHAN, its subsidiaries and associated companies, their directors and employees ("SHAREKHAN and affiliates") are under no obligation to update or keep the information current. Also, there may be regulatory, compliance, or other reasons that may prevent SHAREKHAN and affiliates from doing so. We do not represent that information contained herein is accurate or complete and it should not be relied upon as such. This document is prepared for assistance only and is not intended to be and must not alone betaken as the basis for an investment decision. The user assumes the entire risk of any use made of this information. Each recipient of this document should make such investigations as it deems necessary to arrive at an independent evaluation of an investment in the securities of companies referred to in this document (including the merits and risks involved), and should consult its own advisors to determine the merits and risks of such an investment. The investment discussed or views expressed may not be suitable for all investors. We do not undertake to advise you as to any change of our views. Affiliates of Sharekhan may have issued other reports that are inconsistent with and reach different conclusion from the information presented in this report. This report is not directed or intended for distribution to, or use by, any person or entity who is a citizen or resident of or located in any locality, state, country or other jurisdiction, where such distribution, publication, availability or use would be contrary to law, regulation or which would subject SHAREKHAN and affiliates to any registration or licensing requirement within such jurisdiction. The securities described herein may or may not be eligible for sale in all jurisdictions or to certain category of investors. Persons in whose possession this document may come are required to inform themselves of and to observe such restriction. SHAREKHAN & affiliates may have used the information set forth herein before publication and may have positions in, may from time to time purchase or sell or may be materially interested in any of the securities mentioned or related securities. SHAREKHAN may from time to time solicit from, or perform investment banking, or other services for, any company mentioned herein. Without limiting any of the foregoing, in no event shall SHAREKHAN, any of its affiliates or any third party involved in, or related to, computing or compiling the information have any liability for any damages of any kind. Any comments or statements made herein are those of the analyst and do not necessarily reflect those of SHAREKHAN." | | | |
posted by Anonymous @ 9:01 AM  |
|
|
|
|